Sonya Weigle
Public Communications Contact chez MARINUS PHARMACEUTICALS, INC.
Provenance du réseau au premier degré de Sonya Weigle
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
PA Options for Wellness, Inc.
 PA Options for Wellness, Inc. Pharmaceuticals: OtherHealth Technology PA Options for Wellness, Inc. operates as a medical cannabis research company focused on medical advancements through cannabis-based therapies. The company was founded by Thomas A. Trite in 2014 and is headquartered in Harrisburg, PA.
7
| Private Company | Pharmaceuticals: Other | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sonya Weigle via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer General Counsel | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Biomedical Sciences Careers Program, Inc. | Director/Board Member | ||
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Hospitality Homes | Chairman | ||
| THE MEDICINES COMPANY | Pharmaceuticals: Major | General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Graduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree | |
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | General Counsel | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| METAGENOMI, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Biotrack, Inc. | Chief Operating Officer | ||
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | Investment Managers | Consultant / Advisor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Columbia Law School | College/University | Graduate Degree | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | President | |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer | |
| Carmine Therapeutics, Inc. | Director/Board Member | ||
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Medical Specialties | Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chairman | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 47 |
| Inde | 2 |
| Irlande | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 8 |
| Finance | 3 |
| Retail Trade | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 107 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 42 |
| Chairman | 21 |
| Undergraduate Degree | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Nicole Vitullo | 29 |
| Scott Braunstein | 26 |
| Joseph A. Williamson | 22 |
| Michael Dougherty | 18 |
| Tim Mayleben | 18 |
| Elan Ezickson | 17 |
| Seth Fischer | 17 |
| Sarah Noonberg | 17 |
| Santiago Arroyo | 14 |
| Martha Manning | 13 |
| Christine Silverstein | 11 |
| Sara Nochur | 11 |
| Steven Pfanstiel | 8 |
| Joseph Hulihan | 7 |
| Michael S. Saporito | 6 |
- Bourse
- Insiders
- Sonya Weigle
- Connexions Sociétés
